Type: 
News
Intended audience: 
General public
ATAGI statement

The referred fact sheet provides the ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.

ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.